Delcath Executives Lead Insider Buy‑Spree Amid Quiet 0.01% Share Dip and 3.23% Weekly Gain
Delcath Systems insider buying spree: executives buy 84k+ shares via options and RSUs, hinting at confidence in future liver‑cancer product prospects and potential share rally.
2 minutes to read